Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation

Research output: Contribution to journalArticle

Abstract

Radiotracers targeting prostate-specific membrane antigen (PSMA), including [18F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [18F]DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0).

Original languageEnglish (US)
Pages (from-to)22-25
Number of pages4
JournalUrology Case Reports
Volume17
DOIs
StatePublished - Mar 1 2018

Keywords

  • Carcinoid
  • Prostate cancer
  • PSMA

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation'. Together they form a unique fingerprint.

  • Cite this